A recent study by the latter group showed that FOXP3 isoforms containing exon 2 increase stronger than FOXP3 isoforms lacking exon 2 in peripheral CD4+ T cells of patients suffering from a moderate stage of chronic obstructive pulmonary disease (60). This evidence concerns the gene FOXP3 and chronic obstructive pulmonary disease.